In this issue:
Prognostic significance of TIL grade in melanoma
Comorbidity burden on receipt of adjuvant immunotherapy and survival in stage III melanoma
Nivolumab for unresectable or metastatic mucosal melanoma
A retrospective study of fatal pediatric melanoma
Factors predicting toxicity and response following isolated limb infusion for melanoma
Outcomes of radical vs conservative primary resection in ARM
Ano-uro-genital mucosal melanoma UK national guidelines
Melanoma risk in patients treated with biologic therapy for common inflammatory diseases
Pituitary dysfunction induced by ICIs and better OS in malignant melanoma and NSCLC
Please login below to download this issue (PDF)